Author

R. Lassauniere

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 4 Organism:human· 3 Organism:mouse· 2 Assay:metagenomics· 1 Assay:proteomics· 1

Frequent Co-Authors

M. Rasmussen· 3 shared A. Fomsgaard· 2 shared D. Bailey· 2 shared N. Thakur· 2 shared A. Boklund· 1 shared A. Botner· 1 shared A. H. Patel· 1 shared A. M. E. Elrefaey· 1 shared

Activity by Year

2021-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

M. Rasmussen

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Global variation in prior exposure shapes antibody neutralization profiles of SARS-CoV-2 variants up to BA.2.86

S. Turner, G. Amirthalingam, D. Bailey, D. H. Barouch, K. R. Bewley, K. Brown, Y. R. Cao, Y.-W. Chan, S. Charlton, DOVE consortium, N. S. Coombes, B. Hallis, D. D. Ho, F. Jian, N. Lasrado, , D. J. Smith

The paper analyzes antibody neutralization data from multiple countries to assess how prior exposure to SARS-CoV-2 variants affects neutralization profiles of BA.2.86 and its descendants.

bioRxiv · Mar 27, 2024 · PreprintImmunology

Neutralisation of SARS-CoV-2 Omicron subvariants BA.2.86 and EG.5.1 by antibodies induced by earlier infection or vaccination

R. Lassauniere, C. Polacek, S. Baig, K. Ellegaard, L. A. Escobar-Herrera, A. Fomsgaard, K. Spiess, O. Schwartz, D. Planas, E. Simon-Loriere, U. V. Schneider, R. N. Sieber, M. Stegger, T. G. Krause, H. Ullum, , M. Rasmussen

The paper assesses the neutralization of SARS-CoV-2 Omicron subvariants BA.2.86 and EG.5.1 by antibodies from prior infection or vaccination, finding comparable neutralization titres to XBB.1 and EG.5.1.

bioRxiv · Oct 1, 2023 · PreprintImmunology

Mutations that adapt SARS-CoV-2 to mustelid hosts do not increase fitness in the human airway.

J. Zhou, T. P. Peacock, J. C. Brown, D. H. Goldhill, A. M. E. Elrefaey, R. Penrice-Randal, V. M. Cowton, G. De Lorenzo, W. Furnon, W. T. Harvey, R. Kugathasan, R. Frise, L. Baillon, R. Lassauniere, N. Thakur, , W. S. Barclay

The paper identifies spike mutations that adapt SARS-CoV-2 to mustelid hosts and assesses their impact on human infectivity and antigenicity.

bioRxiv · Aug 20, 2021 · PreprintMicrobiology

Infection, recovery and re-infection of farmed mink with SARS-CoV-2

T. B. Rasmussen, J. Fonager, C. S. Jorgensen, R. Lassauniere, A. S. Hammer, M. L. Quaade, A. Boklund, L. Lohse, B. Strandbygaard, M. Rasmussen, T. Y. Michaelsen, S. Mortensen, A. Fomsgaard, G. J. Belsham, A. Botner

This study shows that mink can recover from SARS-CoV-2 infection, become seropositive, and then be re-infected, with higher antibody levels post-re-infection.

bioRxiv · May 7, 2021Microbiology